Results and KPIs Highlight Continued Execution Against Growth Plans; 2026 and 2027 Guidance Increased
Results are presented in accordance with
Highlights:
- Revenue of
$11.3 million for the second quarter of 2026, compared with$8.0 million in the second quarter of 2025, an increase of 41% (36% excluding the newMichigan wholesale excise tax reported as revenue). Growth was driven primarily by revenue increases of 65% inNew Jersey , 49% inMichigan (31% excluding the excise tax) and 14% inOregon . - Adjusted EBITDA: Adjusted EBITDA (non-GAAP) of
$2.1 million and Adjusted EBITDA margin of 18.2% (18.9% excluding the excise tax), compared with Adjusted EBITDA of$1.5 million and Adjusted EBITDA margin of 18.9% in the second quarter of 2025. - GAAP net income (loss): GAAP net loss of
$1.5 million for the second quarter of 2026, compared with GAAP net income of$1.7 million in the prior-year period. Second quarter 2026 results included approximately$0.8 million of net non-cash fair-value losses related to derivative and warrant instruments. - Cash position: The Company ended the quarter with cash and cash equivalents of
$11.5 million , providing funding flexibility to support its ongoing expansion projects inNew Jersey ,Illinois andMinnesota . New Jersey : Continued strong demand and sell-through for packaged, branded products, with 100% ofNew Jersey revenue generated from packaged products. The Company now has approximately 10,000 square feet of flowering canopy online, with an additional 6,000 square feet under development toward total flowering capacity of approximately 16,000 square feet by year-end.Illinois : Following regulatory approval in June,Grown Rogue's partner, SEA Craft, began cultivation operations at the Dwight facility. The first room was populated in early June, and approximately 5,000 square feet of flowering canopy is now online. An additional 5,000 square feet is approved and anticipated to be operational by year-end. Initial sales are expected in the fourth quarter of 2026. SEA Craft's operating results are not consolidated in the Company's financial results for the periods presented.Minnesota : Construction continued at theFridley cultivation facility. Phase I includes approximately 8,000 square feet of flowering canopy, with the first rooms targeted to be populated late in the third quarter and first revenue expected in the first quarter of 2027, subject to regulatory approvals, construction and commissioning timelines.Oregon andMichigan : Mature markets remained competitive, with second quarter results reflecting both continued pricing volatility and recent operating improvements. Management remained focused on cost per pound, "A" flower yield, packaged-product mix and targeted systems and infrastructure investments that can be applied across the Company's markets. InOregon , indoor bulk ASP increased to$592 per pound from$480 in Q1. InMichigan , total flower yield reached 90 g/sf, cost per pound improved to$277 and "A" flower yield increased to 56 g/sf, compared with 52 g/sf in Q1 and 45 g/sf in Q2 2025.- Product expansion: The Company continued the measured rollout of its single-source cured-resin vape products in
Oregon , with plans to bring these products toMichigan andNew Jersey later this year, and is preparing to launch infused pre-rolls inNew Jersey before year end. Management continues to view deliberate product expansion around its core flower-forward ethos as a capital-efficient way to grow wallet share and generate greater value from select biomass streams. - Guidance: Management increased its 2026 revenue guidance to
$38 million to$41 million , from$34 million to$37 million , and its Adjusted EBITDA guidance to$7 million to$9 million , from$6 million to$8 million . Management also increased 2027 revenue guidance to$55 million to$63 million , from$50 million to$58 million , while maintaining its previously announced 2027 Adjusted EBITDA guidance and long-term growth objectives. - Investor relations website: Subsequent to the quarter, the Company launched an updated dedicated Investor Relations website at ir.grownrogue.com, providing improved centralized access to financial results, press releases,
SEC and SEDAR+ filings, governance materials, presentations, events, stock information and investor email alerts.
Management Commentary
"The second quarter reflected our continued focus on disciplined execution in our existing markets while expanding our platform to serve more customers across the US. 2026 has been a big year of growth for us as we work to complete the
"From a financial standpoint,
"We are building a foundation of people and systems that can travel across markets without losing the quality and consistency that define
"Excluding the
"Based on our second quarter performance and current expectations for the balance of the year, we are updating our 2026 and 2027 guidance. Our outlook continues to recognize that
"During the quarter, investors could begin to see the two principal components of our growth framework operating side by side.
Second Quarter 2026 Update
Second quarter results reflected continued execution across
Management continues to evaluate each market through a focused set of operating KPIs, including total and "A" flower yield, cost per pound, average selling price and packaged-product mix. These metrics help the Company remain disciplined, identify areas for improvement and make informed operating decisions across the platform. Selected market KPIs are presented below.
Operating KPIs by Market | |||||||||
Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | |||||
Total Flower Harvested (lbs) | 3,594 | 3,277 | 2,980 | 3,547 | 3,392 | ||||
Flower Cost Per Pound Produced | |||||||||
Total Flower Yield (g/sf)¹ | 76 | 69 | 68 | 73 | 72 | ||||
"A" Flower Yield (g/sf)¹ | 53 | 50 | 42 | 49 | 45 | ||||
$ Bulk Flower ASP² | |||||||||
$ Packaged Flower ASP² | - | - | - | - | - | ||||
Portion of Revenue for Packaged Products | 10 % | 11 % | 9 % | 15 % | 13 % | ||||
Total Flower Harvested (lbs) | 4,259 | 3,746 | 3,960 | 3,518 | 3,391 | ||||
Flower Cost Per Pound Produced | |||||||||
Total Flower Yield (g/sf)¹ | 90 | 84 | 82 | 77 | 71 | ||||
"A" Flower Yield (g/sf)¹ | 56 | 52 | 49 | 46 | 45 | ||||
$ Bulk Flower ASP2/3 | |||||||||
$ Packaged Flower ASP2/3 | |||||||||
Portion of Revenue for Packaged Products | 27 % | 20 % | 24 % | 17 % | 17 % | ||||
Total Flower Harvested (lbs) | 1,910 | 1,700 | 1,678 | 1,306 | 1,546 | ||||
Flower Cost Per Pound Produced | |||||||||
Total Flower Yield (g/sf)¹ | 61 | 63 | 64 | 59 | 58 | ||||
"A" Flower Yield (g/sf)¹ | 41 | 37 | 37 | 38 | 32 | ||||
$ Bulk Flower ASP² | n.m.4 | n.m.4 | |||||||
$ Packaged Flower ASP2,5 | |||||||||
Portion of Revenue for Packaged Products | 100 % | 97 % | 95 % | 92 % | 93 % | ||||
* Includes only indoor operations 5 | |||||||||
Selected Second Quarter 2026 Financial Results (Unaudited)
Metric | Q2 2026 | Q2 2025 | YoY Change | Q1 2026 |
Revenue (GAAP) | 41 % | |||
Gross Profit | 51 % | |||
Gross Margin | 47.6 % | 44.4 % | 326 bps | 43.2 % |
GAAP Net Income (Loss) | n.m. | |||
EBITDA (Non-GAAP) | 38 % | |||
Adjusted EBITDA (Non-GAAP) | 36 % | |||
Adjusted EBITDA Margin | 18.2 % | 18.9 % | -67 bps | 17.1 % |
Cash and Cash Equivalents |
|
| 20 % |
|
n.m. = not meaningful. EBITDA and Adjusted EBITDA are non-GAAP financial measures. See "Non-GAAP Financial Measures" and the reconciliation tables included below. Reported Q2 2026 revenue includes approximately
Selected Quarterly Financial Results by Segment (Unaudited)
Metric | Q2 2026 | Q2 2025 | YoY Change | Q1 2026 |
Revenue (GAAP) | 14 % | |||
Adjusted EBITDA | 12 % | |||
Adjusted EBITDA Margin | 20.8 % | 21.2 % | -50 bps | 14.2 % |
Revenue (GAAP) | 49 % | |||
Adjusted EBITDA | 11 % | |||
Adjusted EBITDA Margin | 20.0 % | 26.8 % | -680 bps | 19.6 % |
Revenue (GAAP) | 65 % | |||
Adjusted EBITDA | 70 % | |||
Adjusted EBITDA Margin | 42.2 % | 40.8 % | 140 bps | 44.2 % |
Corporate | ||||
Adjusted EBITDA | 44 % | |||
Consolidated | ||||
Revenue (GAAP) | 41 % | |||
Adjusted EBITDA | 36 % | |||
Adjusted EBITDA Margin | 18.2 % | 18.9 % | -70 bps | 17.1 % |
* |
Guidance and Long-Term (3-5 Year) Growth Objectives
Management is updating the financial framework introduced in
Growth Framework
- Selective new builds in undersupplied markets where craft-quality flower is expected to earn attractive wholesale economics and support the capital intensity of new-build projects.
- Fixer-upper takeovers and distressed opportunities where management believes disciplined execution can improve yield, consistency, and cost controls, typically with lower capital expenditure requirements.
- Focused product expansion, including flower-forward vape formats, intended to grow wallet share while maintaining a disciplined SKU set and consistent quality standards.
- Underwriting discipline based on mature-market, normalized pricing assumptions, without relying on perpetual early-cycle pricing upside to meet return targets.
Long-term (3-5 year) Targets and Guidance
- Long-term (3-5 year) targets, using 2027 as the base year
- Revenue growth of 25% per year, compounded
- Profit growth (Adjusted EBITDA1) of 35% per year, compounded
- Return on
Incremental Invested Capital ("ROIIC")2 of greater than 75%
- 2026 Guidance (Revenue / Adjusted EBITDA1): $38–$41 million (up from $34–$37 million) / $7–$9 million (up from $6–$8 million).
- 2027 Guidance (Revenue / Adjusted EBITDA1): $55–$63 million (up from $50–$58 million) / $14–$18 million.
1 Adjusted EBITDA (non-GAAP) excludes pre-revenue, startup expenses associated with new market expansion. |
2 ROIIC (non-GAAP) is defined as the change in operating profit divided by the change in invested capital over the relevant measurement period. |
2026 Guidance Assumptions: 2026 guidance excludes the start-up (pre-revenue) expenses in both
2027 Guidance Assumptions: 2027 guidance assumes modest wholesale price normalization from 2026 levels in
General Assumptions. Guidance and long-term objectives exclude any potential changes in
Flower Capacity
On average,
State | Canopy / capacity | Under development | Nameplate capacity | Notes |
14,752 | N/A | 14,752 | Approximately 30,000 sq. ft. of indoor facility space at the Airport facility. | |
14,550 | N/A | 14,550 | Facility currently operates approximately 50,000 sq. ft., including fourteen | |
10,000 | 6,000 | 16,000 | Expansion underway through 2026, with total flowering canopy anticipated | |
N/A | 8,000 | 30,000 | Phase I includes approximately 8,000 sq. ft. of flowering canopy, with | |
5,000 | 5,000 | 14,000 | Approximately 66,000 sq. ft. leased facility, including a 23,000 sq. ft. | |
Totals | 44,302 | 19,000 | 89,302 |
Conference Call and Webcast Information
Conference Call Details
Date: | |
Time: | |
Webcast: | |
Dial-in: | 1-800-836-8184 (toll-free in |
A telephone replay will be available until
The earnings release, webcast, replay information, transcript, financial filings and related investor materials will be available on the Company's Investor Relations website at ir.grownrogue.com. Investors may also access press releases,
About
The contents of the Company's website are not incorporated by reference into this press release or into any report or document filed or furnished by the Company with the
Condensed Consolidated Statements of Income (Loss) and Comprehensive Income (Loss)
For the three and six months ended June 30, 2026 and 2025
(Expressed in
Three months ended | Six months ended | |||||||||||||
2026 | 2025 | 2026 | 2025 | |||||||||||
$ | $ | $ | $ | |||||||||||
Revenue | ||||||||||||||
Product sales | 11,273,837 | 8,009,987 | 20,429,495 | 15,160,170 | ||||||||||
Total revenue | 11,273,837 | 8,009,987 | 20,429,495 | 15,160,170 | ||||||||||
Cost of goods sold | ||||||||||||||
Cost of finished cannabis inventory sold | (5,903,860) | (4,455,502) | (11,101,884) | (8,241,938) | ||||||||||
Total cost of goods sold | (5,903,860) | (4,455,502) | (11,101,884) | (8,241,938) | ||||||||||
Gross profit | 5,369,977 | 3,554,485 | 9,327,611 | 6,918,232 | ||||||||||
Operating expenses | ||||||||||||||
Amortization (Notes 9, 10) | 65,650 | 107,927 | 156,812 | 212,911 | ||||||||||
General and administrative | 4,318,584 | 2,678,372 | 7,930,407 | 5,210,626 | ||||||||||
Share-based compensation (Note 15) | 149,087 | 336,825 | 304,081 | 1,772,735 | ||||||||||
Total operating expenses | 4,533,321 | 3,123,124 | 8,391,300 | 7,196,272 | ||||||||||
Income (loss) from operations | 836,656 | 431,361 | 936,311 | (278,040) | ||||||||||
Other income (expense) | ||||||||||||||
Interest expense (Note 11, 12) | (429,240) | (432,553) | (979,220) | (690,724) | ||||||||||
Other income (expense) | (116,128) | (173,887) | 49,140 | 623,069 | ||||||||||
Interest income | 104,356 | 36,337 | 146,543 | 72,274 | ||||||||||
Unrealized gain (loss) on derivative liability (Note 12) | 82,006 | (2,892,027) | 148,383 | (27,654) | ||||||||||
Realized gain on derivative liability (Note 12) | - | 5,889,032 | - | 5,859,744 | ||||||||||
Unrealized loss on warrant asset (Note 6) | (556,583) | (168,162) | (2,747,667) | (1,340,654) | ||||||||||
Unrealized gain (loss) on warrant liability (Note 12) | (337,167) | - | 433,547 | - | ||||||||||
Loss on equity investment in associate (Note 7) | (193,593) | (114,686) | (293,250) | (268,420) | ||||||||||
Total other income (expense), net | (1,446,349) | 2,144,054 | (3,242,524) | 4,227,635 | ||||||||||
Income (loss) before income tax expense | (609,693) | 2,575,415 | (2,306,213) | 3,949,595 | ||||||||||
Income tax expense (Note 17) | (871,331) | (920,037) | (1,388,202) | (1,551,347) | ||||||||||
Net income (loss) | (1,481,024) | 1,655,378 | (3,694,415) | 2,398,248 | ||||||||||
Other comprehensive income | ||||||||||||||
Currency translation adjustment | - | (6,547) | - | 1,285 | ||||||||||
Total comprehensive income (loss) | (1,481,024) | 1,648,831 | (3,694,415) | 2,399,533 | ||||||||||
Basic income (loss) per share | (0.01) | 0.01 | (0.02) | 0.01 | ||||||||||
Basic weighted average number of subordinate voting common shares outstanding | 249,938,980 | 247,015,784 | 249,926,825 | 237,157,649 | ||||||||||
Diluted income (loss) per share | (0.01) | 0.01 | (0.02) | 0.01 | ||||||||||
Diluted weighted average number of subordinate voting common shares outstanding | 249,938,980 | 252,922,833 | 249,926,825 | 243,607,029 | ||||||||||
Net income (loss) for the period attributable to: | ||||||||||||||
Shareholders | (1,692,836) | 1,499,975 | (4,395,053) | 2,098,757 | ||||||||||
Non-controlling interest | 211,812 | 155,403 | 700,638 | 299,491 | ||||||||||
Net income (loss) | (1,481,024) | 1,655,378 | (3,694,415) | 2,398,248 | ||||||||||
Total comprehensive income (loss) for the period attributable to: | ||||||||||||||
Shareholders | (1,692,836) | 1,322,312 | (4,395,053) | 2,100,042 | ||||||||||
Non-controlling interest | 211,812 | 326,519 | 700,638 | 299,491 | ||||||||||
Total comprehensive income (loss) | (1,481,024) | 1,648,831 | (3,694,415) | 2,399,533 | ||||||||||
Condensed Consolidated Balance Sheets
As at
(Expressed in
June 30, | December 31, | ||||||
$ | $ | ||||||
ASSETS | |||||||
Current assets | |||||||
Cash and cash equivalents | 11,532,826 | 11,371,834 | |||||
Accounts receivable, net (Note 4) | 3,675,083 | 2,908,270 | |||||
Inventory (Note 5) | 6,714,122 | 7,081,295 | |||||
Prepaid expenses | 355,531 | 563,912 | |||||
Derivative asset (Note 12) | 11,342 | - | |||||
Current portion of notes receivable (Note 8) | 265,972 | 253,403 | |||||
Total current assets | 22,554,876 | 22,178,714 | |||||
Other long-term assets | 300,000 | 300,000 | |||||
Warrants asset (Note 6) | 2,355,605 | 5,103,272 | |||||
Other investments (Note 7) | 1,480,610 | 1,358,860 | |||||
Notes receivable (Note 8) | 1,756,032 | 1,683,757 | |||||
Lease receivable | 94,022 | 94,022 | |||||
Property and equipment, net (Note 9) | 17,820,475 | 14,055,552 | |||||
Right of use assets (Note 10) | 13,838,966 | 13,414,406 | |||||
Deferred tax asset | 1,795,003 | 1,522,760 | |||||
Intangible assets | 3,025,193 | 3,025,193 | |||||
TOTAL ASSETS | 65,020,782 | 62,736,536 | |||||
LIABILITIES | |||||||
Current liabilities | |||||||
Accounts payable and accrued liabilities | 2,544,834 | 1,262,519 | |||||
Current portion of operating lease liabilities (Note 10) | 1,020,063 | 844,421 | |||||
Current portion of finance lease liabilities (Note 10) | 158,219 | 152,705 | |||||
Current portion of long-term debt (Note 11) | 3,002,684 | 2,576,228 | |||||
Current portion of business acquisition consideration payable | 464,486 | 455,844 | |||||
Derivative liability | - | 137,041 | |||||
Warrant liabilities (Note 12) | 1,106,118 | - | |||||
Income tax payable | 412,770 | 296,018 | |||||
Total current liabilities | 8,709,174 | 5,724,776 | |||||
Operating lease liabilities (Note 10) | 13,404,472 | 13,010,805 | |||||
Finance lease liabilities (Note 10) | 40,565 | 67,782 | |||||
Long-term debt (Note 11) | 9,730,478 | 10,019,301 | |||||
Business acquisition consideration payable | 1,545,805 | 1,611,637 | |||||
Other non-current liabilities | 9,830,257 | 8,383,888 | |||||
TOTAL LIABILITIES | 43,260,751 | 38,818,189 | |||||
Commitments and contingencies (Note 23) | |||||||
Subsequent events (Note 24) | |||||||
SHAREHOLDERS' EQUITY | |||||||
Subordinate voting common shares, convertible into multiple voting common shares, | 61,375,330 | 62,589,075 | |||||
Multiple voting common shares, no par value; unlimited shares authorized; nil and nil | - | - | |||||
Accumulated other comprehensive loss | (121,906) | (121,906) | |||||
Accumulated deficit | (45,959,008) | (41,563,955) | |||||
Equity attributable to shareholders | 15,294,416 | 20,903,214 | |||||
Non-controlling interests (Note 22) | 6,465,615 | 3,015,133 | |||||
TOTAL SHAREHOLDERS' EQUITY | 21,760,031 | 23,918,347 | |||||
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | 65,020,782 | 62,736,536 | |||||
Statement of Changes in Cash Flows
For the six months ended
(Expressed in
2026 | 2025 | ||||||
$ | $ | ||||||
Operating activities | |||||||
Net income (loss) | (3,694,415) | 2,398,248 | |||||
Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability | |||||||
Depreciation of property and equipment | 156,812 | 212,911 | |||||
Depreciation of property and equipment included in costs of finished cannabis inventory | 1,577,038 | 795,337 | |||||
Lease costs included in costs of finished cannabis inventory sold | 542,497 | 927,805 | |||||
Share-based compensation | 304,081 | 1,772,735 | |||||
Interest and accretion expense | 979,220 | 690,724 | |||||
Other income | - | (5,251) | |||||
Interest income | (84,844) | (72,274) | |||||
Unrealized (gain) loss on derivative liability | (148,383) | 27,654 | |||||
Realized (gain) loss on derivative liability | - | (5,859,744) | |||||
Unrealized loss on warrant asset | 2,747,667 | 1,340,654 | |||||
Unrealized gain on warrant liability | (433,547) | - | |||||
Loss on equity investment in associate | 293,250 | 268,420 | |||||
Deferred income taxes | (272,243) | (55,184) | |||||
Changes in operating assets and liabilities (Note 18) | 2,280,732 | (3,098,916) | |||||
Net cash provided by (used in) operating activities | 4,247,865 | (656,881) | |||||
Investing activities | |||||||
Purchase of property and equipment | (5,498,773) | (241,532) | |||||
Payments of business acquisition consideration payable | (377,988) | (254,828) | |||||
Investment in | (415,000) | (468,000) | |||||
Net cash used in investing activities | (6,291,761) | (964,360) | |||||
Financing activities | |||||||
Sale of non-controlling interest in GRMA, net of issuance costs | 2,985,000 | - | |||||
Proceeds from exercise of stock options | 21,839 | 402,844 | |||||
Proceeds from long-term debt | 1,000,000 | 7,471,063 | |||||
Distributions to non-controlling interests in subsidiaries | (235,156) | (70,000) | |||||
Debt issuance costs | - | (246,913) | |||||
Repayment of long-term debt | (1,529,295) | (1,169,064) | |||||
Payment of interest on convertible debentures | - | (79,755) | |||||
Repayment of finance lease | (37,500) | (6,250) | |||||
Net cash provided by financing activities | 2,204,888 | 6,301,925 | |||||
Effect of foreign exchange on cash and cash equivalents | - | 1,285 | |||||
Change in cash and cash equivalents | 160,992 | 4,681,969 | |||||
Cash and cash equivalents, beginning of period | 11,371,834 | 4,917,708 | |||||
Cash and cash equivalents, ending of period | 11,532,826 | 9,599,677 | |||||
Adjusted EBITDA Reconciliation Table (Unaudited)
For the three and six months ended
(Expressed in
Three Months Ended | Six Months Ended | |||||||||||||||
2026 | 2025 | 2026 | 2025 | |||||||||||||
Net income (loss) | (1,481,024) | 1,655,378 | (3,694,415) | 2,398,249 | ||||||||||||
Add back amortization of property and equipment included in | 754,506 | 658,232 | 1,577,037 | 1,092,435 | ||||||||||||
Add back interest and accretion expense | 429,240 | 432,553 | 979,220 | 690,724 | ||||||||||||
Add back amortization of property and equipment | 65,650 | 107,927 | 156,812 | 212,911 | ||||||||||||
Add back loss on equity investment in associate | 193,593 | 114,686 | 293,250 | 268,420 | ||||||||||||
Add back income tax expense | 871,331 | 920,037 | 1,388,202 | 1,551,347 | ||||||||||||
Deduct gain on derivative liability | (82,006) | (2,997,005) | (148,383) | (5,832,090) | ||||||||||||
Deduct interest and other income (expense) | 11,772 | 137,550 | (195,683) | (695,343) | ||||||||||||
Add back changes in FV on warrants asset and liability | 893,750 | 168,162 | 2,314,120 | 1,340,654 | ||||||||||||
EBITDA | 1,656,812 | 1,197,520 | 2,670,160 | 1,027,306 | ||||||||||||
Add back share-based compensation | 149,087 | 336,825 | 304,081 | 1,772,735 | ||||||||||||
Deduct GAAP bad debt conversion adjustment | - | (79,000) | - | (158,000) | ||||||||||||
Add back Golden Harvests acquisition costs | - | 60,000 | - | 60,000 | ||||||||||||
Add back pre-operational startup costs1 | 250,997 | - | 647,162 | - | ||||||||||||
Adjusted EBITDA | 2,056,896 | 1,515,345 | 3,621,403 | 2,702,041 | ||||||||||||
1 During the three and six months ended |
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This press release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable Canadian and
Forward-looking statements are often identified by words or phrases such as "may," "would," "could," "should," "will," "intend," "plan," "anticipate," "believe," "estimate," "expect," "target," "guidance," "outlook," "forecast," "objective" and similar expressions, including their negative forms. The absence of these words does not mean that a statement is not forward-looking.
Forward-looking statements are based on management's current expectations, estimates, assumptions and projections as of the date of this release. These assumptions include, without limitation, assumptions regarding market conditions, wholesale pricing, consumer and retailer demand, competitive conditions, construction and commissioning timelines, the availability and cost of labour, materials and equipment, regulatory approvals and continued compliance with applicable licensing requirements, cultivation yields and product quality, the timing of new product and market launches, operating costs, access to capital and the Company's ability to fund its planned operations and expansion activities.
Although the Company believes these expectations and assumptions are reasonable, forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from those expressed or implied. These risks and uncertainties include, without limitation: changes in general economic, business, political and financial-market conditions; changes in cannabis laws, regulations or enforcement policies; the timing or availability of required regulatory approvals; the continued illegality of cannabis under
Readers are cautioned not to place undue reliance on forward-looking statements. The Company does not undertake any obligation to update or revise any forward-looking statement as a result of new information, future events or otherwise, except as required by applicable law. Future-oriented financial information and financial outlooks contained in this release are provided for the purpose of describing management's current expectations and may not be appropriate for other purposes.
The Company is indirectly involved, through its operating subsidiaries, in the cultivation, manufacture, possession, use, sale and distribution of cannabis in the adult-use cannabis marketplace in
NON-GAAP FINANCIAL MEASURES
This press release presents certain financial measures that are not calculated in accordance with
Management uses these non-GAAP financial measures as supplemental tools to evaluate the Company's underlying operating performance, compare results between periods and markets, and assess capital-allocation decisions. These measures should not be considered in isolation or as a substitute for, or superior to, financial measures prepared in accordance with GAAP.
Reconciliations of historical non-GAAP financial measures to the most directly comparable GAAP measures are included in the financial schedules accompanying this release. The specific adjustments used to calculate EBITDA and Adjusted EBITDA are identified in those reconciliation schedules.
The Company has not provided a quantitative reconciliation of its forward-looking Adjusted EBITDA guidance to the most directly comparable forward-looking GAAP measure because certain components of that GAAP measure cannot be reasonably predicted without unreasonable effort. These items could be material and could cause actual GAAP results to differ materially from the forward-looking non-GAAP guidance presented in this release.
SOURCE